Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031611
Filing Date
2024-08-13
Accepted
2024-08-13 16:06:00
Documents
41
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 586643
2 ex31-1.htm EX-31.1 8055
3 ex31-2.htm EX-31.2 8047
4 ex32-1.htm EX-32.1 4522
5 ex32-2.htm EX-32.2 4551
  Complete submission text file 0001493152-24-031611.txt   2466853

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE irme-20240630.xsd EX-101.SCH 19150
7 XBRL CALCULATION FILE irme-20240630_cal.xml EX-101.CAL 24526
8 XBRL DEFINITION FILE irme-20240630_def.xml EX-101.DEF 65876
9 XBRL LABEL FILE irme-20240630_lab.xml EX-101.LAB 158915
10 XBRL PRESENTATION FILE irme-20240630_pre.xml EX-101.PRE 126461
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 267455
Mailing Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE SUITE 500 NEW YORK NY 10151
Business Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE SUITE 500 NEW YORK NY 10151 6467684285
IR-Med, Inc. (Filer) CIK: 0001839133 (see all company filings)

EIN.: 844516398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56492 | Film No.: 241201382
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)